Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-22-001606
Filing Date
2022-02-14
Accepted
2022-02-14 08:55:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 JOUNCE THERAPEUTICS, INC. p22-0659sc13ga.htm SC 13G 65387
  Complete submission text file 0000902664-22-001606.txt   66957
Mailing Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014
Business Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014 646-597-6980
RTW INVESTMENTS, LP (Filed by) CIK: 0001493215 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Subject) CIK: 0001640455 (see all company filings)

EIN.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89831 | Film No.: 22625804
SIC: 2836 Biological Products, (No Diagnostic Substances)